Sign In

Samuel Bjork

VC / Entrepreneur

Samuel Bjork is a Partner at Digitalis Ventures, where he leads the firm’s life sciences practice.12 He has served as a director on the boards of multiple companies, including Bonum Therapeutics, Elemental Machines, EpiBiologics, Judo Bio, and T-Therapeutics.2 He has also been a board director of PetMedix (acquired by Zoetis) and a board observer of Good Therapeutics (acquired by Roche), ScoutBio (acquired by Ceva), SeQure Dx (acquired by MaxCyte), Nuvig Therapeutics, and Switch Therapeutics.2 Prior to his role at Digitalis Ventures, Samuel Bjork was a member of the healthcare and clean energy practices at the Boston Consulting Group.123

Samuel Bjork received graduate degrees from Cambridge and Oxford University as a Marshall Scholar and an A.B. in Chemistry from Harvard University.1234 He has also held the position of Strategic Advisor at Columbia Technology Ventures and engaged in research activities at the University of Cambridge and Harvard University. Bjork also worked as a Researcher + Production Assistant at Fourth Floor Productions under the Office of Errol Morris.

Highlights

Jan 1 · bcic.bio.org
Samuel Bjork - CEO and Investor Conference 2025
Samuel Bjork - Digitalis Ventures
Samuel Bjork - Digitalis Ventures
People - Digitalis Ventures
People - Digitalis Ventures
Oct 7 · signal.nfx.com
Samuel Bjork's Investing Profile - Digitalis Ventures Partner | Signal
Dec 9 · vcsheet.com
Samuel Bjork - Digitalis Ventures - VC Sheet

Related Questions

What are some of the companies Samuel Bjork has invested in?
How did Samuel Bjork transition from the Boston Consulting Group to Digitalis Ventures?
What is Samuel Bjork's educational background?
What are the main focus areas of Digitalis Ventures under Samuel Bjork's leadership?
How has Samuel Bjork's experience in life sciences influenced his investment strategy?
Samuel Bjork
Samuel Bjork, photo 1
Samuel Bjork, photo 2
Add to my network

Location

Greater New York City Area